News
![](https://www.aim-mutual.org/wp-content/uploads/2022/09/shutterstock_343048862-scaled.jpg)
AIM publishes its Special Briefing
AIM published its Special Briefing on the meetings that took place onl...
23.12.2022- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2022/12/Boletin-Informativo_Diciembre2022.png)
AIM Special Newsletter for Latin-America – 4th Issue
AIM published the third issue of its Newsletter for its Latin-American...
23.12.2022- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2022/12/shutterstock_244843513-scaled.jpg)
Air Quality: AIM co-signs joint Letter to EU Environment Ministers
AIM, together with HEAL, CPME, EFA, AIM, EPHA and Mutualites Libres wr...
16.12.2022- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2021/04/rubanaveccopyright.png)
AIM welcomes the Adoption of evidence-based Council Recommendations on Cancer Screening
AIM welcomes the adoption of the Council Recommendation on Cancer Scre...
12.12.2022- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2022/12/EU-Global-Health-Strategy.jpg)
EU Global Health Strategy: ambitions are high, now mutuals should be more involved
The European Commission unveiled its Global Health Strategy on 30 Nove...
02.12.2022- Read more
![](https://www.aim-mutual.org/wp-content/uploads/2022/11/ASCERTAIN_LinkedIn-1.png)
AIM is part of the ASCERTAIN project to secure access to affordable medicinal products to European patients
AIM participates in a European project on affordability of medicinal p...
28.11.2022- Read more